HIGHLIGHTS
- who: Diyang Lyu from the Capital Medical University, Beijing, China have published the research work: Effects of different kinds of anti-Alzheimeru2019s disease drugs on cognitive improvement: protocol for a systematic review and network meta-analysis of phase III clinical trials, in the Journal: (JOURNAL)
- what: The authors aim to perform a systematic review and NMA to investigate the rank of efficacy among different kinds of anti-AD drugs. Through this study, the authors will reveal the potential key hypothesis which is most likely to affect the clinical efficacy, and provide evidence for further clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.